Literature DB >> 12890805

Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma.

U Tateishi1, T Hasegawa, Y Beppu, A Kawai, N Moriyama.   

Abstract

AIMS: To determine the relation between clinical outcome and tumour grade defined by a MIB-1 (Ki-67) score based grading system.
METHOD: The clinical and pathological features of 50 patients with myxoid liposarcoma were evaluated, and MIB-1 immunostaining was performed to grade these patients' tumours. Univariate and multivariate analyses were conducted to evaluate survival. Clinical follow up details were available for all patients (median, 46.5 months; range, 9-408).
RESULTS: Univariate analysis revealed that the tumour site (p < 0.05), round cell component content (p < 0.01), necrosis (p < 0.01), mitosis (p < 0.01), MIB-1 labelling index (p < 0.001), and tumour grade (p < 0.001) had a significant impact on overall survival. Multivariate analysis showed that, of the variables evaluated, the tumour grade defined by a MIB-1 score based grading system was the most significant adverse prognostic factor.
CONCLUSION: Tumour grade determined by the grading system using the MIB-1 score (MIB-1 system) is a very strong prognostic factor in patients with myxoid liposarcoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890805      PMCID: PMC1770031          DOI: 10.1136/jcp.56.8.579

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Liposarcoma. A study of 103 cases.

Authors:  F M ENZINGER; D J WINSLOW
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1962

2.  Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.

Authors:  T Hasegawa; R Yokoyama; Y H Lee; T Shimoda; Y Beppu; S Hirohashi
Journal:  Oncology       Date:  2000       Impact factor: 2.935

3.  Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas.

Authors:  Tadashi Hasegawa; Seiichiro Yamamoto; Takayuki Nojima; Takanori Hirose; Takashi Nikaido; Katsushige Yamashiro; Yoshihiro Matsuno
Journal:  Hum Pathol       Date:  2002-01       Impact factor: 3.466

4.  Liposarcoma: a study of 55 cases with a reassessment of its classification.

Authors:  H L Evans
Journal:  Am J Surg Pathol       Date:  1979-12       Impact factor: 6.394

5.  Liposarcoma of the musculoskeletal system.

Authors:  G G Orson; F H Sim; H M Reiman; W F Taylor
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

6.  Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.

Authors:  Tadashi Hasegawa; Seiichiro Yamamoto; Ryohei Yokoyama; Toru Umeda; Yoshihiro Matsuno; Setsuo Hirohashi
Journal:  Cancer       Date:  2002-08-15       Impact factor: 6.860

7.  Liposarcoma. A clinicopathologic subtyping of 52 cases.

Authors:  H Hashimoto; M Enjoji
Journal:  Acta Pathol Jpn       Date:  1982-11

8.  Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas.

Authors:  E E Lack; S M Steinberg; D E White; T Kinsella; E Glatstein; A E Chang; S A Rosenberg
Journal:  J Surg Oncol       Date:  1989-08       Impact factor: 3.454

9.  Prognostic factors in liposarcoma.

Authors:  J B Reitan; O Kaalhus; I O Brennhovd; E M Sager; A E Stenwig; K Talle
Journal:  Cancer       Date:  1985-05-15       Impact factor: 6.860

Review 10.  Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases.

Authors:  A M Mandard; J F Petiot; J Marnay; J C Mandard; J Chasle; E de Ranieri; P Dupin; P Herlin; J de Ranieri; A Tanguy
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860

View more
  3 in total

1.  Myxoid liposarcoma with cartilaginous differentiation showing DDIT3 rearrangement.

Authors:  Kayo Suzuki; Taketoshi Yasuda; Kenta Watanabe; Takeshi Hori; Masahiko Kanamori; Tomoatsu Kimura
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

2.  Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.

Authors:  Kunio Iura; Kenichi Kohashi; Yuka Hotokebuchi; Takeaki Ishii; Akira Maekawa; Yuichi Yamada; Hidetaka Yamamoto; Yukihide Iwamoto; Yoshinao Oda
Journal:  J Pathol Clin Res       Date:  2015-03-16

3.  About a case of paratesticular myxoid liposarcoma.

Authors:  Yassine Ayari; Ahmed Sellami; Hamza Boussaffa; Alia Zehani; Sami Ben Rhouma; Yassine Nouira
Journal:  Urol Case Rep       Date:  2018-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.